{"id":152,"date":"2024-05-13T09:37:08","date_gmt":"2024-05-13T09:37:08","guid":{"rendered":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/?p=152"},"modified":"2024-05-13T13:49:15","modified_gmt":"2024-05-13T13:49:15","slug":"immunologia-diabetis","status":"publish","type":"post","link":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/","title":{"rendered":"Explorant la immunologia a diabetis: aven\u00e7os prometedors"},"content":{"rendered":"

En el vertigin\u00f3s m\u00f3n de la medicina, cada dia es presenten noves oportunitats per transformar la forma en qu\u00e8 abordem les malalties cr\u00f2niques. En el cas de la diabetis tipus 1<\/strong>, una condici\u00f3 desafiadora que afecta a milions arreu del m\u00f3n, les \u00faltimes investigacions en el camp de la immunologia<\/strong> estan llan\u00e7ant llum sobre un futur prometedor. Uns assajos cl\u00ednics que obren la possibilitat, cada vegada m\u00e9s real, que puguem oferir tractaments efectius amb immunoter\u00e0pia per a la diabetis tipus 1<\/strong>. Vegem com…<\/p>\n

<\/p>\n

Teplizumab i Baricitinib: avan\u00e7os clau en immunologia per a la diabetis<\/h2>\n

El tancament de l’any 2022 va marcar un hito significatiu amb l’aprovaci\u00f3 per part de la FDA de l’\u00fas de teplizumab<\/strong><\/a>, un f\u00e0rmac dissenyat per reduir el risc o retardar el desenvolupament de la diabetis tipus 1<\/strong> en persones amb un risc extremadament alt de desenvolupar-la. Aquest avan\u00e7 no nom\u00e9s representa una esperan\u00e7a per aquells en risc, sin\u00f3 que tamb\u00e9 obre noves possibilitats en el tractament preventiu d’aquesta malaltia.<\/p>\n

\n

\"Dr.\u201cL’aprovaci\u00f3 per part de la FDA de l’\u00fas de teplizumab per reduir el risc o retardar el desenvolupament de la diabetis tipus 1 obre noves possibilitats en el tractament preventiu d’aquesta malaltia<\/strong>\u201d<\/h4>\n

Dr. Jes\u00fas Blanco<\/strong><\/a>, endocrin\u00f2leg del Cl\u00ednic Barcelona i de barnacl\u00ednic+<\/p><\/blockquote>\n

Resultats encoratjadors en investigacions recents sobre immunologia i diabetis<\/h3>\n

Tanmateix, la veritable emoci\u00f3 va arribar amb la fi de l’any 2023. La prestigiosa revista m\u00e8dica NEJM<\/a> va publicar un editorial i dos articles que van revelar resultats encoratjadors sobre l’\u00fas de teplizumab<\/a> i baricitinib<\/a> en el tractament de la diabetis tipus 1<\/strong> despr\u00e9s del diagn\u00f2stic. Aquests medicaments, que regulen la interacci\u00f3 dels gl\u00f2buls blancs i modifiquen l’acci\u00f3 de les citocines proinflamat\u00f2ries, mostren la capacitat de reduir l’atac del sistema immune contra les c\u00e8l\u00b7lules productores d’insulina.<\/p>\n

Un futur prometedor en la intersecci\u00f3 d’immunologia i diabetis<\/h2>\n

L’efecte resultant \u00e9s la reducci\u00f3 de la p\u00e8rdua progressiva de la capacitat de secreci\u00f3 d’insulina, una signatura distintiva de la diabetis tipus 1<\/strong>. Com va assenyalar el Professor Ludvigsson en l’editorial de NEJM<\/a>, aquests assajos cl\u00ednics s\u00f3n un indici prometedor que aviat podr\u00edem oferir tractaments efectius amb immunoter\u00e0pia per a pacients amb diabetis tipus 1 en les primeres etapes de la malaltia.<\/p>\n

\n

\"Dr.<\/h4>\n

\u201cAquests assajos cl\u00ednics s\u00f3n un indici prometedor que aviat podr\u00edem oferir tractaments efectius amb immunoter\u00e0pia per a pacients amb diabetis tipus 1 en les primeres etapes de la malaltia\u201d<\/h4>\n

Dr. Jes\u00fas Blanco<\/strong><\/a>, endocrin\u00f2leg del Cl\u00ednic Barcelona i de barnacl\u00ednic+<\/p><\/blockquote>\n

\n

TE PUEDE INTERESAR\u2026<\/h4>\n

\u00b7 \u00c9s possible endarrerir la diabetis com a vitamina D?<\/a><\/h4>\n

\u00b7 Despr\u00e9s del diagn\u00f2stic de diabetis, qu\u00e8 faig?<\/a><\/h4>\n<\/div>\n

Cam\u00ed cap a la implementaci\u00f3 de tractaments d’immunologia en diabetis<\/h2>\n

Encara que aquests avan\u00e7os encara no estan disponibles en tots els entorns m\u00e8dics, els investigadors estan treballant durament per portar aquests tractaments innovadors a aquells que m\u00e9s els necessiten. Un dels estudis leaders en aquest camp \u00e9s el Diagnode-3<\/strong><\/a>, liderat pel Professor Ludvigsson a la Universitat de Link\u00f6ping (Su\u00e8cia)<\/a>. Aquest estudi t\u00e9 com a objectiu investigar si l’administraci\u00f3 d’un component cel\u00b7lular espec\u00edfic pot millorar l’evoluci\u00f3 de la diabetis en persones joves<\/strong> poc despr\u00e9s del diagn\u00f2stic<\/a>.
\nEn resum, estem al l\u00edmit d’un canvi significatiu en el tractament de la diabetis tipus 1<\/strong>. Amb els avan\u00e7os en immunologia<\/strong>, aviat podr\u00edem tenir la capacitat d’intervenir i modificar la resposta del sistema immune contra les c\u00e8l\u00b7lules productores d’insulina, la qual cosa podria transformar radicalment la forma en qu\u00e8 enfrontem aquesta malaltia cr\u00f2nica.<\/p>\n

\n
\n

Desitges m\u00e9s informaci\u00f3 o vols contactar amb el Dr. Jes\u00fas Blanco?<\/span><\/h3>\n

SOL\u00b7LICITAR CITA<\/a> SOL\u00b7LICITAR TELEVISITA<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

En el vertigin\u00f3s m\u00f3n de la medicina, cada dia es presenten noves oportunitats per transformar la forma en qu\u00e8 abordem les malalties cr\u00f2niques. En el cas de la diabetis tipus 1, una condici\u00f3 desafiadora que afecta a milions arreu del m\u00f3n, les \u00faltimes investigacions en el camp de la immunologia estan llan\u00e7ant llum sobre un […]<\/p>\n","protected":false},"author":2,"featured_media":149,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[12,39,101,104,102],"yoast_head":"\nExplorant la immunologia a diabetis: aven\u00e7os prometedors<\/title>\n<meta name=\"description\" content=\"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Explorant la immunologia a diabetis: aven\u00e7os prometedors\" \/>\n<meta property=\"og:description\" content=\"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog de Enfermedades Digestivas y Metab\u00f3licas\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-13T09:37:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-13T13:49:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/wp-content\/uploads\/sites\/15\/2024\/05\/Inmunologia-diabetes.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"barnacl\u00ednic+\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"barnacl\u00ednic+\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/\",\"url\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/\",\"name\":\"Explorant la immunologia a diabetis: aven\u00e7os prometedors\",\"isPartOf\":{\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#website\"},\"datePublished\":\"2024-05-13T09:37:08+00:00\",\"dateModified\":\"2024-05-13T13:49:15+00:00\",\"author\":{\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07\"},\"description\":\"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Explorant la immunologia a diabetis: aven\u00e7os prometedors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#website\",\"url\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/\",\"name\":\"Blog de Enfermedades Digestivas y Metab\u00f3licas\",\"description\":\"Este es el blog de Enfermedades Digestivas y Metab\u00f3licas de barnacl\u00ednic+. Informaci\u00f3n sobre enfermedades que afectan al aparato digestivo, al sistema endocrino y al metabolismo.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07\",\"name\":\"barnacl\u00ednic+\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2dceb63b73aa111ce672136eaa610fd2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2dceb63b73aa111ce672136eaa610fd2?s=96&d=mm&r=g\",\"caption\":\"barnacl\u00ednic+\"},\"url\":\"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/author\/alex\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Explorant la immunologia a diabetis: aven\u00e7os prometedors","description":"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/","og_locale":"ca_ES","og_type":"article","og_title":"Explorant la immunologia a diabetis: aven\u00e7os prometedors","og_description":"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...","og_url":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/","og_site_name":"Blog de Enfermedades Digestivas y Metab\u00f3licas","article_published_time":"2024-05-13T09:37:08+00:00","article_modified_time":"2024-05-13T13:49:15+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/wp-content\/uploads\/sites\/15\/2024\/05\/Inmunologia-diabetes.png","type":"image\/png"}],"author":"barnacl\u00ednic+","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"barnacl\u00ednic+","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/","url":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/","name":"Explorant la immunologia a diabetis: aven\u00e7os prometedors","isPartOf":{"@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#website"},"datePublished":"2024-05-13T09:37:08+00:00","dateModified":"2024-05-13T13:49:15+00:00","author":{"@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07"},"description":"Recents investigacions donen llum sobre un futur prometedor en l'\u00fas de la immunologia per al tractament de la diabetis tipus 1...","breadcrumb":{"@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/immunologia-diabetis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/"},{"@type":"ListItem","position":2,"name":"Explorant la immunologia a diabetis: aven\u00e7os prometedors"}]},{"@type":"WebSite","@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#website","url":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/","name":"Blog de Enfermedades Digestivas y Metab\u00f3licas","description":"Este es el blog de Enfermedades Digestivas y Metab\u00f3licas de barnacl\u00ednic+. Informaci\u00f3n sobre enfermedades que afectan al aparato digestivo, al sistema endocrino y al metabolismo.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07","name":"barnacl\u00ednic+","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2dceb63b73aa111ce672136eaa610fd2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2dceb63b73aa111ce672136eaa610fd2?s=96&d=mm&r=g","caption":"barnacl\u00ednic+"},"url":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/author\/alex\/"}]}},"_links":{"self":[{"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/posts\/152"}],"collection":[{"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/comments?post=152"}],"version-history":[{"count":3,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/posts\/152\/revisions"}],"predecessor-version":[{"id":158,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/posts\/152\/revisions\/158"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/media\/149"}],"wp:attachment":[{"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/media?parent=152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/categories?post=152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/digestivo\/ca\/wp-json\/wp\/v2\/tags?post=152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}